TY - JOUR
T1 - Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial
AU - Garg, Amit X
AU - Kurz, Andrea
AU - Sessler, Daniel
AU - Cuerden, Meaghan
AU - Robinson, Andrea
AU - Mrkobrada, Marko
AU - Parikh, Chirag
AU - Mizera, Richard
AU - Jones, Philip
AU - Tiboni, Maria
AU - Font, Adria
AU - Cegarra, Virginia
AU - Gomez, Maria Fernanda Rojas
AU - Meyhoff, Christinan S
AU - VanHelder, Tomas
AU - Chan, Matthew T V
AU - Torres, David
AU - Parlow, Joel
AU - de Nadal Clanchet, Miriam
AU - Amir, Mohammed
AU - Bidgoli, Sayed Javad
AU - Pasin, Laura
AU - Martinsen, Kristian
AU - Malaga, German
AU - Myles, Paul S
AU - Acedillo, Rey
AU - Roshanov, Pavel S
AU - Walsh, Michael
AU - Dresser, George
AU - Kumar, Priya
AU - Fleischmann, Edith
AU - Villar, Juan Carlos
AU - Painter, Thomas
AU - Biccard, Bruce
AU - Bergese, Sergio
AU - Srinathan, Sadeesh
AU - Cata, Juan P
AU - Chan, Vincent
AU - Mehra, Bhupendra
AU - Wijeysundera, Duminda
AU - Leslie, Kate
AU - Forget, Patrice
AU - Whitlock, Richard
AU - Yusuf, Salim
AU - Devereaux, Philip J
PY - 2014
Y1 - 2014
N2 - IMPORTANCE: Acute kidney injury, a common complication of surgery, is associated with poor outcomes and high health care costs. Some studies suggest aspirin or clonidine administered during the perioperative period reduces the risk of acute kidney injury; however, these effects are uncertain and each intervention has the potential for harm. OBJECTIVE: To determine whether aspirin compared with placebo, and clonidine compared with placebo, alters the risk of perioperative acute kidney injury. DESIGN, SETTING, AND PARTICIPANTS: A 2 x 2 factorial randomized, blinded, clinical trial of 6905 patients undergoing noncardiac surgery from 88 centers in 22 countries with consecutive patients enrolled between January 2011 and December 2013. INTERVENTIONS: Patients were assigned to take aspirin (200 mg) or placebo 2 to 4 hours before surgery and then aspirin (100 mg) or placebo daily up to 30 days after surgery, and were assigned to take oral clonidine (0.2 mg) or placebo 2 to 4 hours before surgery, and then a transdermal clonidine patch (which provided clonidine at 0.2 mg/d) or placebo patch that remained until 72 hours after surgery. MAIN OUTCOMES AND MEASURES: Acute kidney injury was primarily defined as an increase in serum creatinine concentration from the preoperative concentration by either an increase of 0.3mg/dL or greater (=26.5 ?mol/L) within 48 hours of surgery or an increase of 50 or greater within 7 days of surgery. RESULTS Aspirin (n = 3443) vs placebo (n = 3462) did not alter the risk of acute kidney injury (13.4 vs 12.3 , respectively; adjusted relative risk, 1.10; 95 CI, 0.96-1.25). Clonidine (n = 3453) vs placebo (n = 3452) did not alter the risk of acute kidney injury (13.0 vs 12.7 , respectively; adjusted relative risk, 1.03; 95 CI, 0.90-1.18). Aspirin increased the risk of major bleeding. In a post hoc analysis, major bleeding was associated with a greater risk of subsequent acute kidney injury (23.3 when bleeding was present vs 12.3 when bleeding was absent; adjusted hazard ratio, 2.20; 95 CI, 1.72-2.83). Similarly, clonidine increased the risk of clinically important hypotension. In a post hoc analysis, clinically important hypotension was associated with a greater risk of subsequent acute kidney injury (14.3 when hypotensionwas present vs 11.8 when hypotension was absent; adjusted hazard ratio, 1.34; 95 CI, 1.14-1.58). CONCLUSIONS AND RELEVANCE: Among patients undergoing major noncardiac surgery, neither aspirin nor clonidine administered perioperatively reduced the risk of acute kidney injury.
AB - IMPORTANCE: Acute kidney injury, a common complication of surgery, is associated with poor outcomes and high health care costs. Some studies suggest aspirin or clonidine administered during the perioperative period reduces the risk of acute kidney injury; however, these effects are uncertain and each intervention has the potential for harm. OBJECTIVE: To determine whether aspirin compared with placebo, and clonidine compared with placebo, alters the risk of perioperative acute kidney injury. DESIGN, SETTING, AND PARTICIPANTS: A 2 x 2 factorial randomized, blinded, clinical trial of 6905 patients undergoing noncardiac surgery from 88 centers in 22 countries with consecutive patients enrolled between January 2011 and December 2013. INTERVENTIONS: Patients were assigned to take aspirin (200 mg) or placebo 2 to 4 hours before surgery and then aspirin (100 mg) or placebo daily up to 30 days after surgery, and were assigned to take oral clonidine (0.2 mg) or placebo 2 to 4 hours before surgery, and then a transdermal clonidine patch (which provided clonidine at 0.2 mg/d) or placebo patch that remained until 72 hours after surgery. MAIN OUTCOMES AND MEASURES: Acute kidney injury was primarily defined as an increase in serum creatinine concentration from the preoperative concentration by either an increase of 0.3mg/dL or greater (=26.5 ?mol/L) within 48 hours of surgery or an increase of 50 or greater within 7 days of surgery. RESULTS Aspirin (n = 3443) vs placebo (n = 3462) did not alter the risk of acute kidney injury (13.4 vs 12.3 , respectively; adjusted relative risk, 1.10; 95 CI, 0.96-1.25). Clonidine (n = 3453) vs placebo (n = 3452) did not alter the risk of acute kidney injury (13.0 vs 12.7 , respectively; adjusted relative risk, 1.03; 95 CI, 0.90-1.18). Aspirin increased the risk of major bleeding. In a post hoc analysis, major bleeding was associated with a greater risk of subsequent acute kidney injury (23.3 when bleeding was present vs 12.3 when bleeding was absent; adjusted hazard ratio, 2.20; 95 CI, 1.72-2.83). Similarly, clonidine increased the risk of clinically important hypotension. In a post hoc analysis, clinically important hypotension was associated with a greater risk of subsequent acute kidney injury (14.3 when hypotensionwas present vs 11.8 when hypotension was absent; adjusted hazard ratio, 1.34; 95 CI, 1.14-1.58). CONCLUSIONS AND RELEVANCE: Among patients undergoing major noncardiac surgery, neither aspirin nor clonidine administered perioperatively reduced the risk of acute kidney injury.
UR - http://jama.jamanetwork.com/article.aspx?articleid=1936024
U2 - 10.1001/jama.2014.15284
DO - 10.1001/jama.2014.15284
M3 - Article
SN - 0098-7484
VL - 312
SP - 2254
EP - 2264
JO - JAMA
JF - JAMA
IS - 21
ER -